OPKO Health, Inc. (0KCS.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 07:07PM BST
| Previous close | 1.3195 |
| Open | 1.3000 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 1.2705 - 1.3600 |
| 52-week range | 0.8516 - 2.2315 |
| Volume | |
| Avg. volume | 114,049 |
| Market cap | 6.256M |
| Beta (5Y monthly) | 1.81 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y
OPKO Health's (OPK) first-quarter results reflect soft performances despite robust RAYALDEE sales and strength in the Pharmaceuticals segment.
- Insider Monkey
OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript
OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript May 7, 2024 OPKO Health, Inc. misses on earnings expectations. Reported EPS is $-0.11577 EPS, expectations were $-0.09. OPKO Health, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and […]
- Thomson Reuters StreetEvents
Q1 2024 OPKO Health Inc Earnings Call
Q1 2024 OPKO Health Inc Earnings Call
© 2024 Yahoo. All rights reserved.